Amanda Lynn Jackson MD
Gynecologic Oncology
Gynecologic Oncologist
Join to view full profile
2139 Auburn AveCincinnati, OH 45219
Phone+1 513-585-2323
Fax+1 513-585-4893
Dr. Jackson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsFellowship, Gynecologic Oncology, 2014
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 2007 - 2011
Medical University of South CarolinaClass of 2007
Certifications & Licensure
KY State Medical License 2014 - 2027
OH State Medical License 2014 - 2026
NC State Medical License 2011 - 2014
RI State Medical License 2007 - 2011
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Publications & Presentations
PubMed
- Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and end...Angela Nolin, Morgan D Brown, Samantha M Thomas, Kyle C Strickland, Sarah Bean
International Journal of Gynecological Cancer. 2026-08-01 - MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study.Lindsay E Borden, Casey M Cosgrove, Christina R Washington, Samantha M Thomas, Paulina J Haight
Gynecologic Oncology. 2026-08-01 - Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study.Els Van Nieuwenhuysen, Ignace Vergote, Leslie M Randall, Jacqueline Tromp, Domenica Lorusso
Gynecologic Oncology. 2026-04-01
Press Mentions
Investigational ADC Shows Promise in Advanced Endometrial CancerMarch 18th, 2025- Add-on Metformin Promising in ER-Positive Endometrial CancerMarch 16th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
